Page 152 - Live-cellanalysis handbook
P. 152

Live-Cell Analysis Handbook — Third Edition


       Validated cell lines
       NOTE: Detailed protocols are available for some of the validated cell lines by clicking on the cell type name.

                                                                         CELL    CHEMOATTRACTANT (CONCENTRATION
                                                 COATING                SETTING         RANGE TESTED)
           THERAPEUTIC                          (20 ΜL TOP/   SEED DENSITY   TIME
             AREA      CELL TYPE  ASSAY MEDIUM  150 ΜL BOTTOM  (CELLS/WELL)  (MIN)   nM           ng/mL
                                              5 μg/mL Fibronectin
                                              + 0.1% BSA in D-PBS
                        Jurkat   RPMI + 0.5% FBS   50 μg/mL Matrigel   5,000   45-60   SDF-1a (12. 5 – 125)   SDF-1a (100– 1,000)
                                              + 10% FBS in assay
                                             medium (for clustered
                                                cell migration)
                                              20 μg/mL Protein G                 SDF-1a (3.1 – 200)   SDF-1a (24.8 – 1,600)
                        T Cells   RPMI + 0.5% FBS   followed by 5 μg/mL   5,000   45-60   CXCL11 (12.5 – 800)   CXCL11 (103.8 – 6640)
                                                  ICAM                            RANTES (16)    RANTES (125)
                                                                                 C5a (2.6 – 1,900)  C5a (21.6 – 15,770)
                                              50 μg/mL Matrigel
         Non-adherent  IMMUNOLOGY  Neutrophils   RPMI + 0.5% HSA   + 10% FBS in assay   5,000   45-60   LTB4 (1.4 – 1,000)   IL-8 (13.4 – 10,000)
                                                                                 fMLP (1.4 – 1,000)
                                                                                               fMLP (0.6 – 437.6)
                                                                                 IL-8 (1.5 – 1120)
                                                 medium
                                                                                               LTB4 (0.5 – 336.5)
                                              20 μg/mL Protein G
                                                                                  CCL22 (1 – 100)
                                                                                               CCL22 (8.1 – 810)
                                  RPMI + 50%
                                               followed by 5 μg/
                       CCRF-CEM
                                 Human Serum   mL ICAM OR 5 μg/mL   5,000  45-60  SDF-1a (1 – 100)  SDF-1a (8 – 800 nM)
                                                Fibronectin
                                              50 μg/mL Matrigel                  RANTES (08 – 780)  RANTES (0.1 – 100)
                                  RPMI + 0.5%
                        THP-1                + 10% (dialyzed FBS in   5,000   45-60   MIP-1a (0.8 – 780)   MIP-1a (0.1 – 100)
                                  dialyzed FBS
                                               assay medium)                     MCP-1 (12 – 8,600)  MCP-1 (1.4 – 1,000)
                      Differentiated   RPMI + 0.5% FBS   5 μg/mL Fibronectin    2,500   **45-60   C5a (0.5 – 2,000)   C5a (4.2 – 16,600)
                        THP-1                    in D-PBS
                                              50 μg/mL Matrigel
                        Primary
                      Macrophages   RPMI + 0.5% FBS   + 10% FBS in assay   2,000   15-30   C5a (10 – 1000)   C5a (83 – 8,300)
                                                 medium
                                 EBM-2 + ITS +   5 μg/mL Fibronectin    1,000  15  VEGF (0.01 – 2.6)bFGF   VEGF (0.4 – 100)
                VASCULAR         #supplements  10 μg/mL Fibronectin              bFGF (0.06 – 5.8)   FBS (0.4 – 10%)
                                 0.25% FBS With
                                                                                (0.02 – 17.4)FBS (0.4
                                                                                                bFGF (0.4 – 300)
                        HUVEC
                                              + 0.1% BSA in D-PB
                                                                                    – 10%)
                                 EBM-2 + 0.5%
                                                                                                bFGF (0.01-0.1)
                                 FBS + ITS with
                        HMVEC
                                 #supplements  + 0.1% BSA in D-PB  1,000  15       FBS (10%)      FBS (10%)
         Adherent     MDA-MB-231  DMEM + 2.5 FBS  None         1,000      15     FBS (10%) – slight   FBS (10%) – slight
                                   F12 + ITS*
                                                                                        FBS (0.01 – 10)%
                       HT 1080
                                                                                  EGF (0.2 – 1.6)
                                                                                                 EGF (1 – 10n)
                ONCOLOGY          DMEM/F12                                         response       response
                                                               1,000
                                                  None
                                                                          15
                                hydrocortozone +
                        MCF10a  + 10 μg/mL insulin   5 μg/mL Collagen IV in   1,000  15  EGF (0.2 – 17,200)  EGF (0.1 – 1,000)
                                                 0.05M HCl
                                100ng/mL cholera
                                    toxin
       * Insulin-Transferrin-Selenium (Life Technologies Cat# 41400-045)
       # Supplements: EGM-2 singlequot bullet kit (LONZA CC-4176) with growth factors removed and reduced FBS
       ** Cell settling time pre-differentiation





       150
   147   148   149   150   151   152   153   154   155   156   157